Amplifon | AMP - Selling And Administration Expenses


Amplifon reported EUR0 in Selling and Administration Expenses for its fiscal quarter ending in December of 2023.





Selling And Administration Expenses Change Date
Brookdale Senior Living USD 4.2B 22.68M Jun/2026
Cencora USD 1.98B 182.27M Mar/2026
Diasorin EUR 56M 49.25M Mar/2026
Encompass Health USD 897.6M 839.4M Jun/2026
Enovis USD 263.73M 19.08M Jun/2026
GE HealthCare Technologies USD 1.12B 6M Mar/2026
OPKO Health USD 48.61M 1.91M Mar/2026
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026